SUBSCRIBE
SUBSCRIBE

Anavex Life Sciences Corp.

NEWS
TRICON: Clinical Exome Sequencing More Efficient and Unbiased, Says Pathologist
Drug Development
TRICON: Alzheimer’s Drug Saw 80% Reversal in Memory Loss, Say Anavex CEO
February 18, 2015
 · 
2 min read
Load More
JOBS
IN THE PRESS
Press Releases
Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion
December 19, 2025
 · 
4 min read
Press Releases
Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease
December 15, 2025
 · 
4 min read
Press Releases
Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference
November 27, 2025
 · 
6 min read
Press Releases
Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update
November 26, 2025
 · 
11 min read
Press Releases
Anavex Life Sciences to Present at the 44TH ANNUAL J.P. MORGAN Healthcare Conference
November 20, 2025
 · 
3 min read
Press Releases
Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025
November 19, 2025
 · 
3 min read
Press Releases
Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer’s Disease
November 17, 2025
 · 
5 min read
Press Releases
Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group
October 30, 2025
 · 
8 min read
Press Releases
Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’
October 10, 2025
 · 
3 min read
Press Releases
Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program
October 3, 2025
 · 
5 min read
Load More